Lv32
340 积分 2024-04-22 加入
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood–Brain Barrier: The Discovery of AZD1390
1小时前
已完结
Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics
1个月前
已完结
Species similarities and differences in pharmacokinetics
1个月前
已完结
Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds
1个月前
已完结
Prediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model
1个月前
已完结
Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling
1个月前
已完结
De novo development of small cyclic peptides that are orally bioavailable
2个月前
已完结
Plasma Protein Binding of Challenging Compounds
2个月前
已完结
In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System
2个月前
已完结
Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC)
3个月前
已完结
皖公网安备34019202002308
